@Article{chd.2025.058053,
AUTHOR = {Biagio Castaldi, Francesco Prati, Alice Pozza, Irene Cattapan, Jennifer Fumanelli, Domenico Sirico, Giovanni Di Salvo},
TITLE = {Transcatheter Pulmonary Valve Implantation: A State of the Art Review},
JOURNAL = {Structural and Congenital Heart Disease},
VOLUME = {19},
YEAR = {2024},
NUMBER = {5},
PAGES = {513--533},
URL = {http://www.techscience.com/schd/v19n5/59171},
ISSN = {3071-1738},
ABSTRACT = {Congenital heart disease (CHD) affects about 1% of live births. Among them, about 20% will undergo one or more surgical or percutaneous maneuvers on the right ventricle outflow tract or pulmonary valve. Transcatheter pulmonary valve implantation is a recently available less invasive alternative to surgery for treatment of right ventricular outflow tract dysfunction. Thus, residual dysfunction can be treated early and with a lower risk profile. This narrative review aimed to describe the state of the art of percutaneous pulmonary valve implantation.},
DOI = {10.32604/chd.2025.058053}
}